I really like that we are not going to continue

I really like that we are not going to continue to push the Phase 1 trial for Kevetrin until the MTD is determined by DLTs. I think that Leo realizes that recent events have to some extent changed the dynamic for our company. There are forces in the world that would harm CTIX for their own selfish reasons and we can no longer afford to wait patiently.

They could probably have continued to proceed as before with the Kevetrin Phase 1, but that would have most likely pushed the end of the trial into the second or third quarter of 2016. For themselves and all the rest of us shareholders, he and Dr. Menon have decided to move things along. This way we can move on to multiple Phase 2 Kevetrin trials ASAP and get our final report on the Kevetrin Phase 1 from Dana Farber much, much sooner. I very much approve of this strategy.